Company Filing History:
Years Active: 2001
Title: Sridevi Kota: Innovator in Pharmaceutical Development
Introduction
Sridevi Kota is a notable inventor based in Andheri, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical use. Her work focuses on addressing critical health issues, such as diabetes mellitus.
Latest Patents
Sridevi Kota holds a patent for a compound named Mumbaistatin. This invention includes a process for its production and its application as a pharmaceutical. Mumbaistatin is derived from the cultivation of the microorganism HIL-008003 (DSM 11641). It functions as a glucose-6-phosphate translocase inhibitor, which can be utilized in the treatment of diabetes mellitus. The patent also covers the pharmaceutically acceptable salts and derivatives of Mumbaistatin, along with its use in pharmaceutical compositions.
Career Highlights
Sridevi Kota is currently employed at Aventis Pharma Deutschland GmbH. Her role in the company allows her to engage in cutting-edge research and development in the pharmaceutical sector. She has demonstrated a strong commitment to advancing medical science through her innovative work.
Collaborations
Sridevi has collaborated with notable colleagues, including Nirogi Venkata Satya Ramakrishna and Keshavapura Hosamane Sreedhara Swamy. These collaborations have contributed to her success in the field and have fostered a productive research environment.
Conclusion
Sridevi Kota's contributions to pharmaceutical innovation, particularly through her patent for Mumbaistatin, highlight her role as a key figure in the fight against diabetes mellitus. Her work exemplifies the impact of dedicated inventors in advancing healthcare solutions.